Advertisement

Topics

Tetraphase Pharmaceuticals Inc. Company Profile

07:12 EDT 26th March 2017 | BioPortfolio

Tetraphase Pharmaceuticals is a clinical stage biopharmaceutical company utilizing its breakthrough synthetic chemistry technology platform to discover and develop next-generation tetracycline antibiotics that address unmet needs such as the treatment of serious drug-resistant and gram-negative infections. The company has developed an emerging pipeline of potent novel antibiotics that provide a portfolio of intravenous and oral drug candidates with the potential to treat a wide range of infections, including broad-spectrum and selective-spectrum infections. To learn more about Tetraphase, please visit www.tphase.com.


News Articles [1067 Associated News Articles listed on BioPortfolio]

BRIEF-Tetraphase says publishes phase 3 IGNITE1 eravacycline data in JAMA surgery

* Tetraphase pharmaceuticals inc - in trial, eravacycline was well tolerated

BRIEF-Tetraphase Pharmaceuticals files for mixed shelf

* Tetraphase Pharmaceuticals Inc files for mixed shelf of up to $100 million - SEC filing Source text - (http://bit.ly/2fwQ4M0) Further company coverage:

Tetraphase antibiotic may reach up to $700 million in annual sales: CEO

By Bill Berkrot NEW YORK (Reuters) - Tetraphase Pharmaceuticals Inc Chief Executive Guy Macdonald said annual sales of the company's lead experimental antibiotic for serious bacterial infections could...

TetraPhase Pharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

Project Synopsis:Datamonitor's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken...

Tetraphase Pharmaceuticals: 2017 Biotech Comeback Candidate

BRIEF-Tetraphase Pharmaceuticals provides regulatory and clinical update for eravacycline

* Tetraphase Pharmaceuticals provides regulatory and clinical update for eravacycline

Tetraphase Pharmaceuticals Provides Regulatory and Clinical Update for Eravacycline

– Company to Submit MAA for Eravacycline for the Treatment of Complicated Intra-Abdominal Infections to the EMA in Second Half of 2017 – – Phase 3 IGNITE3 Study in Complicated Urinary Tract...

Tetraphase Pharmaceuticals to Present at the 29th Annual ROTH Conference

WATERTOWN, Mass., March 06, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threateni...

Drugs and Medications [0 Results]

None

PubMed Articles [156 Associated PubMed Articles listed on BioPortfolio]

Progress Confirmed for Pharmaceuticals in 2016.

n/a.

Temporal and spatial behavior of pharmaceuticals in Narragansett Bay, Rhode Island, United States.

The behavior and fate of pharmaceutical ingredients in coastal marine ecosystems is not well understood. To address this, the spatial and temporal distribution of 15 high volume pharmaceuticals were m...

Announcing the 2016 Pharmaceuticals Travel Award for Young Investigators.

For the first time in its short history, our journal is able, this year, to support a young researcher in the field of medicinal chemistry by offering a travel grant of 800 CHF.[...].

Estimation of amount of selected pharmaceuticals sorbed onto digested sludge from wastewater treatment plant Bratislava-Petržalka.

Antibiotics and antidepressants are among the most successful drugs used for human therapy. Their concentration in influent on WWTP is relative high and there can be removed by biodegradation or sorpt...

Status of pharmaceuticals in African water bodies: Occurrence, removal and analytical methods.

In this review paper, the milestones and challenges that have been achieved and experienced by African Environmental Scientists regarding the assessment of water pollution caused by the presence of ph...

Clinical Trials [25 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis

This is a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceut...

Phase I Study to Evaluate the Effect of Food on the Pharmacokinetics of Dexibuprofen 300 mg.

To evaluate the interaction of food on the pharmacokinetics of Dexibuprofen 300 mg (Apsen Pharmaceuticals A / S.), after single dose oral administration to healthy subjects of both sexes, ...

Phase I Study to Evaluate the Effect of Food on the Pharmacokinetics of Dexibuprofen 200 mg.

To evaluate the interaction of food on the pharmacokinetics of Dexibuprofen 200 mg (Apsen Pharmaceuticals A / S.) after single dose oral administration to healthy subjects of both sexes, u...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablet Under Fasting Conditions

Subjects to compare the single dose bioavailability of Torrent's Fluoxetine Tablets 20 mg and Sarafem® 20 mg Tablets of Warner Chilcott LLC, USA. Dosing periods of studies were separated ...

Companies [1246 Associated Companies listed on BioPortfolio]

Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals is a clinical stage biopharmaceutical company utilizing its breakthrough synthetic chemistry technology platform to discover and develop next-gen...

Tetraphase Pharmaceuticals

Tetraphase Pharmaceuticals is a clinical-stage life science company with a groundbreaking synthetic chemistry technology platform that has the power to deliver solutions to the gl...

Tetraphase Pharmaceuticals Inc.

Tetraphase Pharmaceuticals is a clinical stage biopharmaceutical company utilizing its breakthrough synthetic chemistry technology platform to discover and develop next-generation...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

More Information about "Tetraphase Pharmaceuticals Inc." on BioPortfolio

We have published hundreds of Tetraphase Pharmaceuticals Inc. news stories on BioPortfolio along with dozens of Tetraphase Pharmaceuticals Inc. Clinical Trials and PubMed Articles about Tetraphase Pharmaceuticals Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tetraphase Pharmaceuticals Inc. Companies in our database. You can also find out about relevant Tetraphase Pharmaceuticals Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record